Sponsor Pipeline

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
35
Active Trials
23
Recruiting
9
Phase 3
10
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06520540
HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects
overall status: Not Yet Recruiting → Unknown
Active Trials by Phase
Phase 4
2
Phase 3
9
Phase 2
3
Phase 1/2
2
Phase 1
19
Active Trials — top 25 of 35
NCT IDTitleConditionStatus
Phase 4
NCT07244003 Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor… T2DM (Type 2 Diabetes Mellitus) Recruiting
NCT07116928 Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes… T2DM (Type 2 Diabetes Mellitus) Not Yet Recruiting
Phase 3
NCT07036172 Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients Obesity Control Recruiting
NCT07082114 A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2… Type 2 Diabetes Recruiting
NCT07193459 Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus Type 2 Diabetes Recruiting
NCT07279194 Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes Obesity & Overweight Recruiting
NCT07394114 A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and… Type 2 Diabetes Recruiting
NCT06885021 Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults Overweight and Obesity Not Yet Recruiting
NCT07417306 A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in… Type 2 Diabetes Not Yet Recruiting
NCT07357831 A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP… Plaque Psoriasis Active, Not Recruiting
NCT07683806 Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic… Seborrheic Dermatitis Not Yet Recruiting
Phase 2
NCT07109700 A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or… Type 2 Diabetes Recruiting
NCT06886126 Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus Obesity Recruiting
NCT07521631 Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes Obesity Recruiting
Phase 1/2
NCT07124936 A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large… Diffuse Large B Cell Lymphoma (DLBCL) Recruiting
NCT07621159 A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced… Colorectal Cancer Metastatic Not Yet Recruiting
Phase 1
NCT06576401 A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects Healthy Adult Subject Recruiting
NCT06615193 A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced… Advanced Solid Tumors Recruiting
NCT06985615 A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement Hepatic Impairment Recruiting
NCT07004296 A Study of HDM2005 in Patients With Advanced Solid Tumor Advanced Solid Tumors Recruiting
NCT07098052 A Study of HDM2020 in Patients With Advanced Solid Tumors Solid Tumor Recruiting
NCT07100249 A Study of HDM2012 in Patients With Advanced Solid Tumor Advanced Solid Tumors Recruiting
NCT07274085 A Phase 1 Study of HDM2017 in Advanced Solid Tumors Solid Tumors Recruiting
NCT07331389 A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam… Overweight Subject Recruiting
NCT07377591 A Study of HDM2006 in Patients With Advanced Solid Tumor Advanced Solid Tumors Recruiting
See all 35 active Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. trials with filters →
Disease Areas
Get alerts when Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free